Article

A network model for patient-derived drug response in breast cancer integrating multi-omics datasets

2025-06-12

Abstract excerpt

The widespread availability of multi-omics tumor profiling has enabled detailed molecular characterization of individual tumors, paving the way for more effective, less toxic, and patient-specific therapies. However, widespread compound screens in human patients are constrained by ethical and logistical challenges, underscoring the need for computational models capable of predicting in vivo drug response. Here, w...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 34eedb66-1400-58e3-bdd7-574984d150aa
DOI: 10.1101/2025.06.09.658757

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A network model for patient-derived drug response in breast cancer integrating multi-omics datasetsDOI 10.1101/2025.06.09.658757Read

BKDRP: A Biological Knowledge-Driven Approach for Drug Response Prediction Using Multi-Omics Data in Cancer Cell LinesSemantic proximity Read

DrugSAGE: an aggregation-based method for drug response imputationSemantic proximity Read

Advancing drug-response prediction using multi-modal and -omics machine learning integration (MOMLIN): a case study on breast cancer clinical dataSemantic proximity Read

DrDimont: Explainable drug response prediction from differential analysis of multi-omics networksSemantic proximity Read

A Network Approach to Identify Biomarkers of Differential Chemotherapy Response Using Patient-Derived Xenografts of Triple-Negative Breast CancerSemantic proximity Read

UniCure: A Foundation Model for Predicting Personalized Cancer Therapy ResponseSemantic proximity Read

Systematic identification of drug-based prognostic biomarkersby integrating multiomics in breast cancerSemantic proximity Read

Integrating Genomic Data with Deep Learning for Personalized Cancer TreatmentSemantic proximity Read

A network-based deep learning model integrating subclonal architecture for therapy response prediction in cancer.Semantic proximity Read

A precision oncology-focused deep learning framework for personalized selection of cancer therapySemantic proximity Read

Retrospective multi-cohort validation of a real-world transcriptomics-guided machine learning model for treatment response prediction in breast cancerSemantic proximity Read

CAN-Scan: A multi-omic phenotype-driven precision oncology platform identifies prognostic biomarkers of therapy response for colorectal cancerSemantic proximity Read